RNA Analysis/Transcriptomics Market by Product (Reagents, Instruments, Software), Technology (Microarrays, NGS, Sanger), Application (Clinical Diagnostics, Drug Discovery), End User (CROs, Hospitals), COVID-19 Impact

The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market. The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market. On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.

Based on product, the reagents/consumables segment holds the largest market share during the forecast period.

Based on product & service, the RNA analysis/Transcriptomics market is segmented into reagents/consumables, instruments, software, and services. The reagents/consumables segment accounted for the larger market share in 2019. The increasing demand for high-quality reagents and the repeated use of media and reagents in transcriptome studies. Additionally, the growing R&D activities in the pharmaceutical industry, growing government investments in the field of life science research, and the increasing research being undertaken with integrated omics studies are contributing to the market for consumables.

Based on technology, the sequencing technologies segment is expected to register the highest CAGR during the forecast period.

Based on technology, the RNA analysis/transcriptomics market is segmented into microarrays, PCR, sequencing technologies (Sanger sequencing and NGS technologies), and RNAi (gene silencing). The sequencing technologies segment is expected to witness the highest growth during the forecast period. RNA sequencing allows direct access to sequences of mRNA and is an equitable technology, which makes it more suitable for target identification and drug discovery applications. RNA sequencing also helps to overcome several issues associated with microarrays, such as bias and variation due to hybridization and labeling efficiencies. Technological advancements in this segment are further set to drive market growth.

The drug discovery segment is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019.

The drug discovery segment accounted for the largest share of the market in 2019. This is attributed to the use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms. The growing need to study a large number of genes to gain a better understanding of gene-to-drug interactions is further expected to drive the use of transcriptomic technologies in drug discovery applications.

CROs end user segment is expected to grow at the highest CAGR in the RNA analysis/transcriptomics market during the forecast period.

Based on end user, the RNA analysis/transcriptomics market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and contract research organizations. The contract research organizations (CROs) segment is expected to witness the highest growth during the forecast period. CROs provide affordable outlets for companies and academia to pursue new medicines and offer a cost-effective solution to developing drugs. They also support foundations, research institutions, and universities, in addition to government organizations, such as the NIH and EMA. These factors are driving the growth of this segment.

North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019.

In 2019, North America accounted for the largest share of the RNA analysis/transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.

Break of primary participants was as mentioned below:

By Company Type - Tier 1-35%, Tier 2-5%, and Tier 3-20%
By Designation - C-level-35%, Director-level-25%, Others-40%
By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the RNA analysis/transcriptomics market

The key players operating in the RNA analysis/transcriptomics market include Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US).

Research Coverage:

The report analyzes the RNA analysis/transcriptomics market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, application, end user, and region. The report also includes a product portfolio matrix of various RNA analysis/transcriptomics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

Market Penetration: Comprehensive information on product portfolios offered by the top players in the global RNA analysis/transcriptomics market. The report analyzes this market by product, technology, application, and end user
Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global RNA analysis/transcriptomics market
Market Development: Comprehensive information on the lucrative emerging markets by product, technology, application, and end user
Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global RNA analysis/transcriptomics market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global RNA analysis/transcriptomics market.

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition & Scope
1.2.1 Inclusions and Exclusions
1.2.2 Markets Covered
Figure 1 RNA Analysis/Transcriptomics Market
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Stakeholders
1.5 Limitations
1.6 Summary of Changes

2 Research Methodology
2.1 Research Approach
Figure 2 Research Design
2.1.1 Secondary Research
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Research
Figure 3 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Breakdown of Primaries
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation
Figure 5 Segmental Share Analysis Illustration
Figure 6 Top-Down Approach
2.3 Data Triangulation Approach
Figure 7 Data Triangulation Methodology
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary
Figure 8 RNA Analysis/Transcriptomics Market, by Product & Service, 2020 Vs. 2025 (USD Million)
Figure 9 RNA Analysis/Transcriptomics Market, by Technology, 2020 Vs. 2025 (USD Million)
Figure 10 RNA Analysis/Transcriptomics Market, by Application, 2020 Vs. 2025 (USD Million)
Figure 11 RNA Analysis/Transcriptomics Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 12 Geographic Analysis: RNA Analysis/Transcriptomics Market

4 Premium Insights
4.1 RNA Analysis/Transcriptomics Market Overview
Figure 13 Increasing Research Being Conducted Using Omics Technologies to Drive Market Growth
4.2 Asia-Pacific: RNA Analysis/Transcriptomics Market, by Technology
Figure 14 Pcr Segment Accounted for the Largest Share of the Asia-Pacific RNA Analysis/Transcriptomics Market in 2019
4.3 RNA Analysis/Transcriptomics Market: Geographic Growth Opportunities
Figure 15 Market in China to Witness the Highest Growth During the Forecast Period
4.4 RNA Analysis/Transcriptomics Market, by Region (2018-2025)
Figure 16 North America Will Continue to Dominate the RNA Analysis/Transcriptomics Market Until 2025
4.5 RNA Analysis/Transcriptomics Market: Developed Vs. Developing Markets
Figure 17 Developing Markets to Register a Higher Growth Rate During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Table 1 RNA Analysis/Transcriptomics Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Increasing Demand for Personalized Medicine
Figure 18 Launch of Personalized Medicine Products, 2008-2016
5.2.1.2 Increasing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding
Figure 19 R&D Investments, by Country, 2017 Vs. 2018 (USD Billion)
5.2.1.3 Growing Applications of RNA Sequencing in Transcriptomics
5.2.2 Restraints
5.2.2.1 High Capital Investments
5.2.3 Opportunities
5.2.3.1 High Growth Opportunities in Emerging Markets
5.2.3.2 Increasing Application of Toxicogenomics
5.2.3.3 Increasing Focus on Biomarker Discovery
5.2.3.4 Rising Focus on Outsourcing
5.2.4 Challenges
5.2.4.1 Data Management in Transcriptomics Research
5.2.4.2 Lack of Effective Bioinformatics Tools
5.2.4.3 Dearth of Skilled Professionals

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Integration of Omics Data in Biomedical Sciences
6.2.2 Growing Focus on Monitoring Post-Translational Modifications
6.2.3 Shift from Plant-Based to Genome-Based Drug Discovery
6.2.4 Spatially Resolved Transcriptomes
6.3 Strategic Benchmarking
Table 2 Product Portfolio Analysis: RNA Analysis/Transcriptomics Market
6.4 Porter's Five Forces Analysis
6.4.1 Threat of New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Buyers
6.4.4 Bargaining Power of Suppliers
6.4.5 Intensity of Competitive Rivalry
6.5 Related Market Analysis
6.6 COVID-19 Impact on the RNA Analysis/Transcriptomics Market

7 RNA Analysis/Transcriptomics Market, by Product & Service
7.1 Introduction
Table 3 RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
7.2 Reagents/Consumables
7.2.1 Reagents/Consumables to Dominate the Market During the Forecast Period
Table 4 RNA Analysis/Transcriptomics Reagents/Consumables Market, by Country, 2018-2025 (USD Million)
7.3 Instruments
7.3.1 The Need for Accurate Analysis is Driving the Adoption of Automated Instruments
Table 5 RNA Analysis/Transcriptomics Instruments Market, by Country, 2018-2025 (USD Million)
7.4 Software
7.4.1 Need for Data Management and Quality Enhancements of Results Obtained Makes Software Solutions an Imperative Part of Transcriptomics
Table 6 RNA Analysis/Transcriptomics Software Market, by Country, 2018-2025 (USD Million)
7.5 Services
7.5.1 Increasing Outsourcing of Services to Propel Market Growth
Table 7 RNA Analysis/Transcriptomics Services Market, by Country, 2018-2025 (USD Million)

8 RNA Analysis/Transcriptomics Market, by Technology
8.1 Introduction
Table 8 RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
8.2 Polymerase Chain Reaction
8.2.1 Real-Time Pcr Aids in the Quantification of Low-Copy Transcripts
Table 9 RNA Analysis/Transcriptomics Pcr Market, by Country, 2018-2025 (USD Million)
8.3 Sequencing
8.3.1 Advances in Ngs Multiplexing Capabilities to Aid Market Growth
Table 10 RNA Analysis/Transcriptomics Sequencing Market, by Country, 2018-2025 (USD Million)
8.4 Microarrays
8.4.1 Wide Adoption of Microarrays in Clinical Diagnostics to Support Market Growth
Table 11 RNA Analysis/Transcriptomics Microarrays Market, by Country, 2018-2025 (USD Million)
8.5 RNA Interference (Gene Silencing)
8.5.1 Technological Advancements are Supporting the Adoption of this Technique for Diagnostics and Therapeutics
Table 12 RNA Analysis/Transcriptomics RNA Interference Market, by Country, 2018-2025 (USD Million)

9 RNA Analysis/Transcriptomics Market, by Application
9.1 Introduction
Table 13 RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
9.2 Drug Discovery
9.2.1 Targeted Sequencing-Based Approaches are Gaining Momentum in the Field of Drug Discovery
Figure 20 R&D Investments in Life Sciences, 2016-2018
Table 14 RNA Analysis/Transcriptomics Market for Drug Discovery, by Country, 2018-2025 (USD Million)
9.3 Clinical Diagnostics
9.3.1 Transcriptomics is Widely Adopted for the Large-Scale Gene Expression Profiling of Oncological Disorders
Table 15 RNA Analysis/Transcriptomics Market for Clinical Diagnostics, by Country, 2018-2025 (USD Million)
9.4 Toxicogenomics
9.4.1 Increasing Focus on Adr Studies is Driving the Adoption of Transcriptomics for Systemic Toxicology
Table 16 RNA Analysis/Transcriptomics Market for Toxicogenomics, by Country, 2018-2025 (USD Million)
9.5 Comparative Transcriptomics
9.5.1 Transcriptional Profiles are Being Widely Adopted to Study the Evolution Among Species
Table 17 RNA Analysis/Transcriptomics Market for Comparative Transcriptomics, by Country, 2018-2025 (USD Million)

10 RNA Analysis/Transcriptomics Market, by End-user
10.1 Introduction
Table 18 RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Increasing Investments for Oncology Therapeutics Driving the Use of Omics Technologies
Table 19 RNA Analysis/Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2018-2025 (USD Million)
10.3 Hospitals & Diagnostic Centers
10.3.1 Use of Whole-Blood Transcriptome Profiles for Disease Diagnostics is Aiding Market Growth
Table 20 RNA Analysis/Transcriptomics Market for Hospitals & Diagnostic Centers, by Country, 2018-2025 (USD Million)
10.4 Academic & Research Institutes
10.4.1 Growing Government Investments to Propel Market Growth
Table 21 RNA Analysis/Transcriptomics Market for Academic & Research Institutes, by Country, 2018-2025 (USD Million)
10.5 Contract Research Organizations
10.5.1 Growing Outsourcing Services by Pharmaceutical Companies for Faster Drug Discovery is Aiding Market Growth
Table 22 RNA Analysis/Transcriptomics Market for Contract Research Organizations, by Country, 2018-2025 (USD Million)

11 RNA Analysis/Transcriptomics Market, by Region
11.1 Introduction
Figure 21 RNA Analysis/Transcriptomics Market: Geographic Snapshot (2019)
Table 23 RNA Analysis/Transcriptomics Market, by Region, 2018-2025 (USD Million)
11.2 North America
Figure 22 North America: RNA Analysis/Transcriptomics Market Snapshot
Table 24 North America: RNA Analysis/Transcriptomics Market, by Country, 2018-2025 (USD Million)
Table 25 North America: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 26 North America: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 27 North America: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 28 North America: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.2.1 US
11.2.1.1 The Us Dominates the North American Market
Table 29 US: Nih Budget for Various Disciplines, Fy 2019 Vs. Fy 2020 (USD Billion)
Table 30 US: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 31 US: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 32 US: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 33 US: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.2.2 Canada
11.2.2.1 Improving Funding and Infrastructure for Omics-Based Research is Supporting Market Growth
Table 34 Canada: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 35 Canada: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 36 Canada: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 37 Canada: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3 Europe
Figure 23 Europe: RNA Analysis/Transcriptomics Market Snapshot
Table 38 Europe: RNA Analysis/Transcriptomics Market, by Country, 2018-2025 (USD Million)
Table 39 Europe: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 40 Europe: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 41 Europe: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 42 Europe: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.1 Germany
11.3.1.1 Germany Holds the Largest Share of the European Market
Table 43 Germany: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 44 Germany: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 45 Germany: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 46 Germany: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.2 France
11.3.2.1 Increasing Government Support for Omics-Based Research in the Country to Support Market Growth
Table 47 France: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 48 France: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 49 France: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 50 France: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.3 UK
11.3.3.1 Rising Public and Private Funding for Research to Drive Market Growth
Table 51 UK: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 52 UK: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 53 UK: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 54 UK: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.4 Italy
11.3.4.1 Growth in this Market is Driven by the Improving R&D Expenditure and Disease Diagnostics
Table 55 Italy: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 56 Italy: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 57 Italy: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 58 Italy: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.5 Switzerland
11.3.5.1 Well-Established Pharmaceutical Industry to Drive Market Growth
Table 59 Switzerland: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 60 Switzerland: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 61 Switzerland: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 62 Switzerland: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.6 Spain
11.3.6.1 Increasing Collaborations for Enhancing Research to Support Market Growth
Table 63 Spain: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 64 Spain: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 65 Spain: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 66 Spain: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.3.7 Rest of Europe
Table 67 Roe: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 68 Roe: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 69 Roe: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 70 Roe: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.4 Asia-Pacific
Figure 24 Asia-Pacific: RNA Analysis/Transcriptomics Market Snapshot
Table 71 Asia-Pacific: RNA Analysis/Transcriptomics Market, by Country, 2018-2025 (USD Million)
Table 72 Asia-Pacific: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 73 Asia-Pacific: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 74 Asia-Pacific: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 75 Asia-Pacific: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.4.1 Japan
11.4.1.1 Early Adoption of Technologically Advanced Products to Drive Market Growth
Table 76 Japan: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 77 Japan: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 78 Japan: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 79 Japan: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.4.2 China
11.4.2.1 China is One of the Fastest-Growing Markets Offering Significant Growth Opportunities
Table 80 China: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 81 China: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 82 China: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 83 China: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.4.3 India
11.4.3.1 Increasing Pharmaceutical R&D Spending and Government Funding for Research to Drive Market Growth
Table 84 India: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 85 India: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 86 India: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 87 India: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.4.4 Rest of Asia-Pacific
Table 88 Roapac: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 89 Roapac: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 90 Roapac: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 91 Roapac: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.5 Latin America
11.5.1 Growth in the Pharmaceutical Industry in Mexico to Support Market Growth
Table 92 Latin America: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 93 Latin America: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 94 Latin America: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 95 Latin America: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)
11.6 Middle East & Africa
11.6.1 Improving Focus on Precision Medicine and Disease Genetics is Driving Market Growth
Table 96 Middle East & Africa: RNA Analysis/Transcriptomics Market, by Product & Service, 2018-2025 (USD Million)
Table 97 Middle East & Africa: RNA Analysis/Transcriptomics Market, by Technology, 2018-2025 (USD Million)
Table 98 Middle East & Africa: RNA Analysis/Transcriptomics Market, by Application, 2018-2025 (USD Million)
Table 99 Middle East & Africa: RNA Analysis/Transcriptomics Market, by End-user, 2018-2025 (USD Million)

12 Competitive Landscape
12.1 Overview
Figure 25 Product Launches-Key Growth Strategy Adopted by Market Players from January 2017 to October 2020
12.2 Market Share Analysis
Figure 26 Ngs Market Share, by Key Player, 2019
Figure 27 Pcr Market Share, by Key Player, 2019
12.3 Company Evaluation Matrix
12.3.1 Stars
12.3.2 Emerging Leaders
12.3.3 Pervasive
12.3.4 Emerging Companies
Figure 28 RNA Analysis Market: Competitive Leadership Mapping (2019)
12.4 Competitive Situation and Trends
12.4.1 Product Launches
Table 100 Product Launches, 2017-2020
12.4.2 Expansions
Table 101 Expansions, 2017-2020
12.4.3 Acquisitions
Table 102 Acquisitions, 2017-2020
12.4.4 Other Strategies
Table 103 Other Strategies, 2017-2020

13 Company Profiles
13.1 Thermo Fisher Scientific, Inc.
Figure 29 Thermo Fisher Scientific, Inc.: Company Snapshot (2019)
13.2 Agilent Technologies, Inc.
Figure 30 Agilent Technologies, Inc.: Company Snapshot (2019)
13.3 Bio-Rad Laboratories, Inc.
Figure 31 Bio-Rad Laboratories, Inc: Company Snapshot (2019)
13.4 Cd Genomics
13.5 Promega Corporation
13.6 Illumina, Inc.
Figure 32 Illumina, Inc.: Company Snapshot (2019)
13.7 Qiagen N.V.
Figure 33 Qiagen N.V.: Company Snapshot (2019)
13.8 Danaher Corporation
Figure 34 Danaher Corporation: Company Snapshot (2019)
13.9 F. Hoffmann-La Roche Ltd.
Figure 35 F. Hoffmann-La Roche Ltd: Company Snapshot (2019)
13.10 Merck KGaA
Figure 36 Merck KGaA: Company Snapshot (2019)
13.11 Fluidigm Corporation
Figure 37 Fluidigm Corporation: Company Snapshot (2019)
13.12 Eurofins Scientific
Figure 38 Eurofins Scientific: Company Snapshot (2019)
13.13 Sequentia Biotech Sl
13.14 Acobiom
13.15 Genxpro GmbH
13.16 Other Companies
13.16.1 Lexogen GmbH
13.16.2 Cenix Bioscience GmbH
13.16.3 Takara Holdings, Inc.
13.16.4 Biomérieux Sa
13.16.5 Lc Sciences, LLC